Gastroesophageal junction carcinoma multimodal treatment: standards, debate and new therapeutic options (Journal article)

Liakakos, T./ Katsios, C./ Roukos, D. H.

Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adenocarcinoma/metabolism/*therapy,Combined Modality Therapy,DNA Methylation,DNA, Neoplasm/metabolism,Esophageal Neoplasms/metabolism/*therapy,*Esophagogastric Junction/drug effects/radiation effects/surgery,Histones/metabolism,Humans,MicroRNAs/metabolism,Receptor, erbB-2/metabolism,Stomach Neoplasms/metabolism/*therapy,Tumor Markers, Biological/metabolism
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/21459
ISSN: 1747-4132
Link: http://www.ncbi.nlm.nih.gov/pubmed/21309665
http://www.expert-reviews.com/doi/pdfplus/10.1586/egh.11.1
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Liakakos-2011-Gastroesophageal jun.pdf434.02 kBAdobe PDFView/Open    Request a copy


 Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/21459
  This item is a favorite for 0 people.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.